Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Agenus reported $13.65M in Debt for its fiscal quarter ending in March of 2023.

Debt Change
Agenus AGEN:US USD 13.65M 490K
Amgen AMGN:US USD 61.6B 22.65B
AstraZeneca AZN:LN USD 31.5B 2.27B
Bristol-Myers Squibb BMY:US USD 37.83B 1.49B
CSL CSL:AU USD 12.12B 2.46B
Dynavax Technologies DVAX:US USD 221.86M 277K
Eli Lilly LLY:US USD 18.88B 2.64B
GlaxoSmithKline GSK:LN GBP 20.9B 82M
Glaxosmithkline GSK:US GBP 20.9B 82M
Incyte Corp INCY:US USD 32.85M 414K
Intrexon XON:US USD 13.82M 29.4M
J&J JNJ:US USD 52.91B 13.25B
Karyopharm Therapeutics KPTI:US USD 303.02M 201K
Merck MRK:GR EUR 10.64B 246M
Northwest Biotherapeutics NWBO:US USD 26.62M 5.1M
Novartis NOVN:VX USD 29.15B 1.24B
Novavax NVAX:US USD 199.05M 350.73M
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Rigel Pharmaceuticals RIGL:US USD 59.48M 20.04M